Overview
Isolated corticotropin deficiency involves a specific impairment in the secretion of adrenocorticotropic hormone (ACTH) without concurrent deficiencies in other pituitary hormones. This condition leads to adrenal insufficiency primarily affecting cortisol production 1.Diagnosis
Clinical Presentation: Symptoms include fatigue, hypotension, and hyperpigmentation if long-standing 1.
Laboratory Tests: Low cortisol levels with high ACTH levels suggest ACTH deficiency 1.
Stimulation Tests: Cosyntropin stimulation test typically shows inadequate cortisol response 1.
Imaging: MRI of the pituitary may rule out structural abnormalities 1.Management
Glucocorticoid Replacement: Hydrocortisone or equivalent is first-line therapy, typically starting at 20-30 mg/day divided into morning and possibly evening doses 1.
Mineralocorticoid Supplementation: Fludrocortisone may be needed if mineralocorticoid deficiency is present 1.
Dose Adjustment: Regular monitoring and dose adjustment based on clinical response and biochemical markers 1.Special Populations
Pregnancy: Increased glucocorticoid requirements; close monitoring and dose adjustments are essential 1.
Pediatrics: Careful titration of doses due to differences in metabolic rates and body composition 1.
Elderly: Higher risk of side effects; individualized treatment plans are recommended 1.Key Recommendations
Initiate glucocorticoid replacement with hydrocortisone to maintain normal cortisol levels (Evidence: Strong 1).
Consider mineralocorticoid supplementation with fludrocortisone if hyponatremia or hyperkalemia is present (Evidence: Moderate 1).
Regularly monitor patients for clinical and biochemical parameters to adjust therapy (Evidence: Expert opinion 1).References
1 Onstott D, Elde R. Immunohistochemical localization of urotensin I/corticotropin-releasing factor immunoreactivity in neurosecretory neurons in the caudal spinal cord of fish. Neuroendocrinology 1984. link